Industry Source Consulting Inc

PINK:INSO USA Drug Manufacturers - Specialty & Generic
Market Cap
$10.94K
Market Cap Rank
#51263 Global
#15954 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$48565.54
About

Industry Source Consulting, Inc. focuses on providing various management services to the legal cannabis industry in the United States and Canada. The company was formerly known as Vega Biofuels, Inc. Industry Source Consulting, Inc. was founded in 1986 and is based in Norcross, Georgia.

Industry Source Consulting Inc (INSO) - Net Assets

Latest net assets as of June 2023: $-565.16K USD

Based on the latest financial reports, Industry Source Consulting Inc (INSO) has net assets worth $-565.16K USD as of June 2023.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.45 Million) and total liabilities ($7.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-565.16K
% of Total Assets -8.76%
Annual Growth Rate 0.08%
5-Year Change 87276.96%
10-Year Change N/A
Growth Volatility 81375.7

Industry Source Consulting Inc - Net Assets Trend (2010–2022)

This chart illustrates how Industry Source Consulting Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Industry Source Consulting Inc (2010–2022)

The table below shows the annual net assets of Industry Source Consulting Inc from 2010 to 2022.

Year Net Assets Change
2022-12-31 $384.01K -62.98%
2021-12-31 $1.04 Million +5024.45%
2020-12-31 $20.24K -97.90%
2019-12-31 $964.02K +219250.38%
2015-12-31 $439.49 -99.89%
2011-12-31 $393.48K +3.45%
2010-12-31 $380.36K --

Equity Component Analysis

This analysis shows how different components contribute to Industry Source Consulting Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 525479900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2022)

Component Amount Percentage
Common Stock $10.44K 2.72%
Other Comprehensive Income $-10.44K -2.72%
Other Components $8.10 Million 2109.87%
Total Equity $384.01K 100.00%

Industry Source Consulting Inc Competitors by Market Cap

The table below lists competitors of Industry Source Consulting Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Industry Source Consulting Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from 1,037,188 to 384,013, a change of -653,175 (-63.0%).
  • Net loss of 32,277 reduced equity.
  • Other comprehensive income decreased equity by 10,439.
  • Other factors decreased equity by 610,459.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income $-32.28K -8.41%
Other Comprehensive Income $-10.44K -2.72%
Other Changes $-610.46K -158.97%
Total Change $- -62.98%

Book Value vs Market Value Analysis

This analysis compares Industry Source Consulting Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.03x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2010-12-31 $0.20 $0.00 x
2011-12-31 $0.20 $0.00 x
2015-12-31 $0.00 $0.00 x
2019-12-31 $0.50 $0.00 x
2020-12-31 $0.00 $0.00 x
2021-12-31 $0.01 $0.00 x
2022-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Industry Source Consulting Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -8.41%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1013.72%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 17.81x
  • Recent ROE (-8.41%) is above the historical average (-854.09%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2010 -35.48% 0.00% 0.00x 1.31x $-172.98K
2011 -136.25% 0.00% 0.00x 1.32x $-575.31K
2015 -51.66% -368.83% 0.11x 1.32x $-271.00
2019 -200.12% -992.39% 0.18x 1.12x $-2.03 Million
2020 -5535.58% -2035.61% 0.11x 24.75x $-1.12 Million
2021 -11.14% -78.97% 0.08x 1.68x $-219.26K
2022 -8.41% -1013.72% 0.00x 17.81x $-70.68K

Industry Comparison

This section compares Industry Source Consulting Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Industry Source Consulting Inc (INSO) $-565.16K -35.48% N/A $0.97
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million